April 7, 2017 / 10:47 AM / 6 months ago

BRIEF-Biotest says Chinese investor Creat to make voluntary public takeover offer

April 7 (Reuters) - Biotest AG:

* Chinese strategic investor Creat to make a voluntary public takeover offer for the shares of Biotest AG

* Tiancheng (Germany) Pharmaceutical Holdings AG announced its decision to make a voluntary public takeover offer for all outstanding ordinary and preference shares of Biotest AG

* Offer will be subject to a minimum acceptance threshold of 75 percent of all ordinary shares as well as regulatory approvals

* To offer for all outstanding ordinary and preference shares of Biotest AG for 28.50 euros ($30.30) per ordinary share and 19.00 euros per preference share in an all-cash transaction

* Biotest was informed that Biotest AG’s majority shareholder, Ogel GmBH, supports transaction Source text for Eikon: Further company coverage: ($1 = 0.9406 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below